Clinical Trial Update: Combination Chemotherapy Plus Oblimersen in Treating Patients With Previously Untreated Extensive-Stage Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial update reports on a Phase 1 study evaluating the safety of combining chemotherapy with Oblimersen in patients with untreated extensive-stage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Oblimersen (oblimersen)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 1 | Status: COMPLETED